BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/23/2026 11:05:52 AM | Browse: 55 | Download: 160
 |
Received |
|
2025-10-11 09:47 |
|
Peer-Review Started |
|
2025-10-11 09:47 |
|
First Decision by Editorial Office Director |
|
2025-11-05 08:14 |
|
Return for Revision |
|
2025-11-05 08:14 |
|
Revised |
|
2025-11-19 02:29 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-02 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-02 07:16 |
|
Articles in Press |
|
2026-02-02 07:16 |
|
Edit the Manuscript by Language Editor |
|
2026-02-05 03:01 |
|
Typeset the Manuscript |
|
2026-03-30 12:16 |
|
Publish the Manuscript Online |
|
2026-04-23 11:05 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Randomized controlled trial of Danggui Sini Decoction in the treatment of lower limb arteriosclerosis obliterans
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan-Bo Fu, Feng Yan, Hong-Jiang Zhu and Cong Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| 2023 Zhangjiajie Municipal Special Fund for Sci-Tech Development |
No. 7 |
|
| Corresponding Author |
Hong-Jiang Zhu, MD, Department of Vascular Interventional Surgery, Zhangjiajie People’s Hospital, No. 192 Guyong Road, Yongding District, Zhangjiajie 415000, Hunan Province, China. 13028176178@163.com |
| Key Words |
Arteriosclerosis obliterans; Danggui Sini Decoction; Endovascular revascularization; Clinical efficacy; Primary patency rate; Quality of life; Target lesion revascularization |
| Core Tip |
This randomized controlled trial demonstrates that adjunctive therapy with Danggui Sini Decoction (DGSD), a classic traditional Chinese medicine formula, significantly enhances the long-term outcomes of endovascular revascularization for arteriosclerosis obliterans. At six months, the DGSD group showed superior clinical effectiveness (94.74% vs 73.68%) and primary patency rates compared to the control group. The combination therapy also led to a greater improvement in quality of life, suggesting DGSD is a valuable complementary treatment for improving vascular patency and patient well-being in arteriosclerosis obliterans management. |
| Publish Date |
2026-04-23 11:05 |
| Citation |
Fu YB, Yan F, Zhu HJ, Wang C. Randomized controlled trial of Danggui Sini Decoction in the treatment of lower limb arteriosclerosis obliterans. World J Methodol 2026; 16(2): 115003
|
| URL |
https://www.wjgnet.com/2222-0682/full/v16/i2/115003.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v16.i2.115003 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
